| Name | Rivercity Eyecare Inc |
|---|---|
| Organization Name | Rivercity Eyecare, Inc |
| Location | 1714 Washington Blvd, Belpre, Ohio 45714 |
| Type | Supplier |
| Phone | (740) 423-9521 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Genzyme, a Sanofi company, announced today that Health Canada has approved Lemtrada (alemtuzumab) for the management of adult patients with relapsing remitting multiple sclerosis, with active disease defined by clinical and imaging features, who have had an inadequate response to interferon beta or other disease-modifying therapies.
A research team from the University of Helsinki, Helsinki University Hospital and Folkhälsan Institute of Genetics in Helsinki, Finland, have identified a new genetic mutation that alters the function of cryopyrin and leads to a life-long periodic inflammation of the cornea, the transparent window of the human eye. Patients who carry the mutation also develop corneal opacities that compromise vision.
The safety of a controversial clot-busting drug has been investigated by researchers, who have shown a modified dosage can reduce serious bleeding in the brain and improve survival rates.
New research from McMaster University suggests the pandemic has created a paradox where mental health has become both a motivator for and a barrier to physical activity.
› Verified 5 days ago
News Archive
Genzyme, a Sanofi company, announced today that Health Canada has approved Lemtrada (alemtuzumab) for the management of adult patients with relapsing remitting multiple sclerosis, with active disease defined by clinical and imaging features, who have had an inadequate response to interferon beta or other disease-modifying therapies.
A research team from the University of Helsinki, Helsinki University Hospital and Folkhälsan Institute of Genetics in Helsinki, Finland, have identified a new genetic mutation that alters the function of cryopyrin and leads to a life-long periodic inflammation of the cornea, the transparent window of the human eye. Patients who carry the mutation also develop corneal opacities that compromise vision.
The safety of a controversial clot-busting drug has been investigated by researchers, who have shown a modified dosage can reduce serious bleeding in the brain and improve survival rates.
New research from McMaster University suggests the pandemic has created a paradox where mental health has become both a motivator for and a barrier to physical activity.
› Verified 5 days ago
Cvs Pharmacy #02394 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1013 Washington Blvd, Belpre, Ohio 45714 Phone: (740) 401-1035 | |
Rite Aid Pharmacy #01430 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 201 Washington Blvd, Belpre, Ohio 45714 Phone: (740) 423-4894 | |
Kroger Pharmacy #799 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1008 Washington Blvd, Belpre, Ohio 45714 Phone: (740) 423-7271 | |
Miller Prosthetics & Orthotics Type: Prosthetic/Orthotic Supplier Location: 2354 Richmiller Ave, Belpre, Ohio 45714 Phone: (740) 421-4211 | |
Rivercity Eyecare Inc Type: Medicare Supplier Location: 1714 Washington Blvd, Belpre, Ohio 45714 Phone: (740) 423-9521 |